Paget's Disease of Bone
Also known as: Paget Disease of Bone / Osteitis deformans of unspecified bone / Paget's disease / Osteitis deformans [Paget's disease of bone] / Osteitis Deformans / Osteitis deformans (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01077 | Etidronic acid | A bisphosphonate drug that prevents osteoclastic bone resorption; used for the prevention and treatment of osteoporosis. |
DB01133 | Tiludronic acid | A bisphosphonate used for the treatment of Paget's disease of bone. |
DB00399 | Zoledronic acid | A bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00630 | Alendronic acid | 3 | Completed | 1 |
DB01373 | Calcium | 3 | Completed | 1 |
DB00884 | Risedronic acid | 3 | Completed | 2 |
DB11094 | Vitamin D | 3 | Completed | 1 |
DB00399 | Zoledronic acid | 3 | Completed | 2 |
DB00630 | Alendronic acid | 4 | Completed | 1 |
DB00282 | Pamidronic acid | 4 | Completed | 1 |
DB00399 | Zoledronic acid | 4 | Completed | 1 |